What is INCR (INCR) stock price today?

INCR (INCR) is currently trading at $5.40, down 2% today.

What is INCR P/E ratio?

INCR's P/E ratio is -1.37. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is INCR return on equity (ROE)?

INCR's return on equity (ROE) is -9.07%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is INCR's market cap?

INCR has a market capitalization of $63.97M.

NGM · Drug Manufacturers - Specialty & Generic

INCR (INCR) Stock

$5.40 -2.00% NGM: INCR Healthcare

Valuation

Metric	Value
Price	$5.40
Market Cap	$63.97M
P/E Ratio	-1.37
P/B Ratio	0.12
P/S Ratio	0.74
EPS (TTM)	$-0.63
52-Week High	$6.06
52-Week Low	$0.68
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-9.07%
ROA	-5.21%
ROCE	1.76%
Gross Margin	2.59%
Operating Margin	2.59%
Net Margin	-19.47%
Debt/Equity	0.46
Current Ratio	1.48

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$220.0M	$389.0M	$356.0M	$239.0M	$270.0M
Operating Profit	$28.0M	$51.0M	$-42.0M	$-67.0M	$7.0M
Net Profit	$5.0M	$45.0M	$-62.0M	$-68.0M	$-36.0M
EPS	$0.11	$0.99	$-1.36	$-1.42	$-0.63
Op Margin	12.8%	13.0%	-11.7%	-28.1%	2.5%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$686.0M	$958.0M	$787.0M	$763.0M	$691.0M
Total Liabilities	$227.0M	$437.0M	$330.0M	$365.0M	$294.0M
Cash	$196.0M	$233.0M	$101.0M	$78.0M	$46.0M
Borrowings	$109.0M	$255.0M	$196.0M	$211.0M	$183.0M

Latest News

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds GlobeNewswire · Jun 22, 2026 InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition MT Newswires · Jun 15, 2026 InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition GlobeNewswire · Jun 15, 2026 InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow GlobeNewswire · Apr 30, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$25.0M	$51.0M	$-54.0M	$-67.0M	$17.0M
Investing Cash Flow	$-79.0M	$-162.0M	$2.0M	$13.0M	$-6.0M
Financing Cash Flow	$3.0M	$-17.0M	$-21.0M	$-15.0M	$-19.0M
Net Cash Flow	$158.0M	$36.0M	$-131.0M	$-23.0M	$-32.0M
Free Cash Flow	$11.0M	$32.0M	$-56.0M	$-71.0M	$13.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	7.66
FCF Yield	6.51%
Quick Ratio	0.97
Interest Coverage	0.35
Return 1Y	-33.26%
Return 3Y	-39.08%
Return 5Y	-83.29%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AMWL	$12.83	+6.30%	-1.32	$218.22M	0.00%
ASRT	$23.44	+0.30%	-4.95	$151.47M	0.00%
BMEA	$1.94	+7.50%	-1.20	$139.90M	0.00%
CAMP	$3.80	+0.26%	-1.70	$80.71M	0.00%
CRDL	$2.17	+0.93%	-3.38	$250.14M	0.00%

About INCR

INCR is led by CEO Alexander Rabinovich, employs 320 people, headquartered in IL, publicly traded since 2019.

INCR stock trades at $5.40 with a market capitalization of $63.97M. The stock is valued at a price-to-earnings (P/E) ratio of -1.37, price-to-book of 0.12, price-to-sales of 0.74. Over the past 52 weeks the stock has ranged between $0.68 and $6.06, and currently trades 10.9% below its 52-week high.

On profitability, INCR generates a return on equity (ROE) of -9.07%, return on capital employed of 1.76%, an operating margin of 2.59%, a net profit margin of -19.47%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides